[HTML][HTML] The impact of sugar consumption on stress driven, emotional and addictive behaviors

A Jacques, N Chaaya, K Beecher, SA Ali… - Neuroscience & …, 2019 - Elsevier
Abstract In 2016 the World Health Organization reported 39% of the world's adult population
(over 18 y) was overweight, with western countries such as Australia and the United States …

Reward, dopamine and the control of food intake: implications for obesity

ND Volkow, GJ Wang, RD Baler - Trends in cognitive sciences, 2011 - cell.com
The ability to resist the urge to eat requires the proper functioning of neuronal circuits
involved in top-down control to oppose the conditioned responses that predict reward from …

Anti-obesity drugs: past, present and future

RJ Rodgers, MH Tschöp… - Disease models & …, 2012 - journals.biologists.com
The ideal anti-obesity drug would produce sustained weight loss with minimal side effects.
The mechanisms that regulate energy balance have substantial built-in redundancy, overlap …

Nutrition for health, fitness, & sport

MH Williams, DE Anderson, ES Rawson - 1999 - just.edu.jo
Jordan University of Science and Technology Page 1 Jordan University of Science and Technology
Faculty of Agriculture Nutrition & Food Technology Department NF386 Athletes Nutrition Second …

Neuronal circuits that regulate feeding behavior and metabolism

JW Sohn, JK Elmquist, KW Williams - Trends in neurosciences, 2013 - cell.com
Neurons within the central nervous system receive humoral and central (neurotransmitter or
neuropeptide) signals that ultimately regulate ingestive behavior and metabolism. Recent …

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: incretin actions beyond the pancreas

Y Seino, D Yabe - Journal of diabetes investigation, 2013 - Wiley Online Library
Glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1)
are the two primary incretin hormones secreted from the intestine on ingestion of various …

[HTML][HTML] Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss

SK Billes, P Sinnayah, MA Cowley - Pharmacological research, 2014 - Elsevier
The mechanism of action of the combination therapy, naltrexone/bupropion (NB), for obesity
has not been fully described to date. Weight loss attempts rarely result in long-term success …

Are dietary proteins the key to successful body weight management? A systematic review and meta-analysis of studies assessing body weight outcomes after …

TT Hansen, A Astrup, A Sjödin - Nutrients, 2021 - mdpi.com
The primary aim was to systematically review the current evidence investigating if dietary
interventions rich in protein lead to improved body weight management in adults with …

CNS regulation of appetite

JA Harrold, TM Dovey, JE Blundell, JCG Halford - Neuropharmacology, 2012 - Elsevier
This article reviews the regulation of appetite from a biopsychological perspective. It
considers psychological experiences and peripheral nutritional systems (both episodic and …

Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity

B Moreno, D Bellido, I Sajoux, A Goday, D Saavedra… - Endocrine, 2014 - Springer
The global prevalence of obesity has significantly increased in most industrialized countries.
Anti-obesity drugs are scarce, and indications to change their life style are impractical …